IRF9 抗体 (AA 44-180)
Quick Overview for IRF9 抗体 (AA 44-180) (ABIN7156637)
抗原
See all IRF9 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 44-180
-
交叉反应
- 人, 小鼠
-
纯化方法
- >95%, Protein G purified
-
免疫原
- Recombinant Human Interferon regulatory factor 9 protein (44-180AA)
-
亚型
- IgG
-
-
anti-Interferon Regulatory Factor 9 (IRF9) (AA 75-104) antibody
IRF9 适用: 人, 小鼠 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-393) antibodyIRF9 适用: 人 WB, ELISA, IHC (p) 宿主: 小鼠 Monoclonal 1C10 unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) antibodyIRF9 适用: 人 IF, FACS 宿主: 小鼠 Monoclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 101-200) antibodyIRF9 适用: 人 WB, ELISA, IF (cc), IF (p), IHC (p), ICC, IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-393) antibodyIRF9 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 171-393) antibodyIRF9 适用: 人 WB, IHC, IF, IHC (p), ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 75-104) antibodyIRF9 适用: 人, 小鼠 WB, IF, IHC (p) 宿主: 兔 Polyclonal RB19229 unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-393) antibodyIRF9 适用: 人 WB, IF 宿主: 小鼠 Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-394) antibodyIRF9 适用: 人 WB, ELISA, IHC, IHC (p) 宿主: 小鼠 Monoclonal 1C10 unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (N-Term) antibodyIRF9 适用: 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 马, 兔, 斑马鱼 WB, IHC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Recommended dilution: WB:1:500-1:5000, IF:1:50-1:200,
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
-
别名
- IRF9
-
背景
-
Background: Transcription factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. IRF9/ISGF3G associates with the phosphorylated STAT1:STAT2 dimer to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state.
Aliases: IFN alpha responsive transcription factor subunit antibody, IFN-alpha-responsive transcription factor subunit antibody, Interferon regulatory factor 9 antibody, interferon stimulated transcription factor 3 antibody, Interferon-stimulated gene factor 3 gamma antibody, interferon-stimulated transcription factor 3, gamma 48 kDa antibody, IRF 9 antibody, IRF-9 antibody, Irf9 antibody, IRF9_HUMAN antibody, ISGF 3 gamma antibody, ISGF-3 gamma antibody, ISGF3 antibody, ISGF3 p48 subunit antibody, ISGF3G antibody, OTTHUMP00000164692 antibody, OTTHUMP00000164693 antibody, p48 antibody, Transcriptional regulator ISGF3 subunit gamma antibody
-
UniProt
- Q00978
-
途径
- JAK/STAT Signaling, Interferon-gamma Pathway, Hepatitis C
抗原
-
